Detalhe da pesquisa
1.
Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
Arch Gynecol Obstet
; 307(4): 1155-1162, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36127525
2.
The systemic treatment of recurrent ovarian cancer revisited.
Ann Oncol
; 32(6): 710-725, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33675937
3.
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors.
Ultrasound Obstet Gynecol
; 58(1): 148-168, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33794043
4.
Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.
Gynecol Oncol
; 159(2): 442-448, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32981695
5.
Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review.
Arch Gynecol Obstet
; 301(2): 315-326, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31616986
6.
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
Ann Oncol
; 30(5): 672-705, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31046081
7.
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.
Gynecol Oncol
; 152(2): 235-242, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30466805
8.
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.
Gynecol Oncol
; 155(2): 186-191, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31519320
9.
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
Ann Oncol
; 29(1): 178-185, 2018 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29069370
10.
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Ann Oncol
; 29(3): 737-743, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29267856
11.
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries.
Ann Oncol
; 29(4): 910-916, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29415128
12.
Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.
Br J Cancer
; 116(3): 287-292, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28006819
13.
Homologous recombination deficiency testing in first-line ovarian cancer.
Ann Oncol
; 33(3): 231-233, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35017033
14.
Treatment of recurrent ovarian cancer.
Ann Oncol
; 28(suppl_8): viii51-viii56, 2017 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29232464
15.
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients.
Ann Oncol
; 28(8): 1803-1810, 2017 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28459941
16.
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.
Ann Oncol
; 28(4): 727-732, 2017 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27993805
17.
Management of borderline ovarian tumors.
Ann Oncol
; 27 Suppl 1: i20-i22, 2016 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27141065
18.
Neoadjuvant chemotherapy in ovarian cancer revisited.
Ann Oncol
; 27 Suppl 1: i30-i32, 2016 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27141067
19.
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Br J Cancer
; 112(4): 660-6, 2015 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-25562434
20.
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
Br J Cancer
; 113(5): 817-26, 2015 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26151456